Review and Recommendations for the Component Tests in the Liver Function Test Profile

Tony Badrick, Peter Turner

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Abstract

Pathology laboratories group some tests that they perform on their high throughput biochemistry analysers into profiles of tests that are associated with different organs (e.g. liver function tests—LFT). The components of these profiles Are historic and often vary between different laboratories. This can lead to confusion and begs the question of what should be in a particular profile. In community medicine profiles may be used as screening tests but some of the components of the profiles may have low sensitivity and specificity and may produce both false positives and negatives. The LFT may include components which are poor liver function tests but are sensitive to fatty liver and hence elevations may cause unnecessary concern. Harmonisation of clinical chemistry reference intervals and units is occurring now so it is time to consider a similar process for components of a profile. A proposed list of analytes to be performed in the LFT profile is given.

Original languageEnglish
Pages (from-to)21-29
Number of pages9
JournalIndian Journal of Clinical Biochemistry
Volume31
Issue number1
Early online date12 May 2015
DOIs
Publication statusPublished - 1 Mar 2016

Fingerprint

Liver Function Tests
Liver
Community Medicine
Clinical Chemistry
Fatty Liver
Biochemistry
Pathology
Sensitivity and Specificity
Medicine
Screening
Throughput

Cite this

@article{1288085e2f4f4be99cdff5406ff7522b,
title = "Review and Recommendations for the Component Tests in the Liver Function Test Profile",
abstract = "Pathology laboratories group some tests that they perform on their high throughput biochemistry analysers into profiles of tests that are associated with different organs (e.g. liver function tests—LFT). The components of these profiles Are historic and often vary between different laboratories. This can lead to confusion and begs the question of what should be in a particular profile. In community medicine profiles may be used as screening tests but some of the components of the profiles may have low sensitivity and specificity and may produce both false positives and negatives. The LFT may include components which are poor liver function tests but are sensitive to fatty liver and hence elevations may cause unnecessary concern. Harmonisation of clinical chemistry reference intervals and units is occurring now so it is time to consider a similar process for components of a profile. A proposed list of analytes to be performed in the LFT profile is given.",
author = "Tony Badrick and Peter Turner",
year = "2016",
month = "3",
day = "1",
doi = "10.1007/s12291-015-0493-1",
language = "English",
volume = "31",
pages = "21--29",
journal = "Indian Journal of Clinical Biochemistry",
issn = "0970-1915",
publisher = "Springer",
number = "1",

}

Review and Recommendations for the Component Tests in the Liver Function Test Profile. / Badrick, Tony; Turner, Peter.

In: Indian Journal of Clinical Biochemistry, Vol. 31, No. 1, 01.03.2016, p. 21-29.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Review and Recommendations for the Component Tests in the Liver Function Test Profile

AU - Badrick, Tony

AU - Turner, Peter

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Pathology laboratories group some tests that they perform on their high throughput biochemistry analysers into profiles of tests that are associated with different organs (e.g. liver function tests—LFT). The components of these profiles Are historic and often vary between different laboratories. This can lead to confusion and begs the question of what should be in a particular profile. In community medicine profiles may be used as screening tests but some of the components of the profiles may have low sensitivity and specificity and may produce both false positives and negatives. The LFT may include components which are poor liver function tests but are sensitive to fatty liver and hence elevations may cause unnecessary concern. Harmonisation of clinical chemistry reference intervals and units is occurring now so it is time to consider a similar process for components of a profile. A proposed list of analytes to be performed in the LFT profile is given.

AB - Pathology laboratories group some tests that they perform on their high throughput biochemistry analysers into profiles of tests that are associated with different organs (e.g. liver function tests—LFT). The components of these profiles Are historic and often vary between different laboratories. This can lead to confusion and begs the question of what should be in a particular profile. In community medicine profiles may be used as screening tests but some of the components of the profiles may have low sensitivity and specificity and may produce both false positives and negatives. The LFT may include components which are poor liver function tests but are sensitive to fatty liver and hence elevations may cause unnecessary concern. Harmonisation of clinical chemistry reference intervals and units is occurring now so it is time to consider a similar process for components of a profile. A proposed list of analytes to be performed in the LFT profile is given.

UR - http://www.scopus.com/inward/record.url?scp=84956629585&partnerID=8YFLogxK

U2 - 10.1007/s12291-015-0493-1

DO - 10.1007/s12291-015-0493-1

M3 - Article

VL - 31

SP - 21

EP - 29

JO - Indian Journal of Clinical Biochemistry

JF - Indian Journal of Clinical Biochemistry

SN - 0970-1915

IS - 1

ER -